APA (7th ed.) Citation

A, R., AE, L., & CM, S. (2004). Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of neurology, 61(1), 97. https://doi.org/10.1001/archneur.61.1.97

Chicago Style (17th ed.) Citation

A, Razmy, Lang AE, and Shapiro CM. "Predictors of Impaired Daytime Sleep and Wakefulness in Patients with Parkinson Disease Treated with Older (ergot) Vs Newer (nonergot) Dopamine Agonists." Archives of Neurology 61, no. 1 (2004): 97. https://doi.org/10.1001/archneur.61.1.97.

MLA (9th ed.) Citation

A, Razmy, et al. "Predictors of Impaired Daytime Sleep and Wakefulness in Patients with Parkinson Disease Treated with Older (ergot) Vs Newer (nonergot) Dopamine Agonists." Archives of Neurology, vol. 61, no. 1, 2004, p. 97, https://doi.org/10.1001/archneur.61.1.97.